Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ·Healthcare·Biotechnology
$35.67
-0.28%
Mkt Cap $2.07B
Analyst Ratings
Buy
3
Hold
4
Sell
1
Price Target (20 analysts)
$44.00
Range $36.00 – $50.00
Implied Upside
+23.4%
Consensus $44.00 vs current $35.67